Insulin secretion in diabetes mellitus.

[1]  J. Halter,et al.  Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide , 1980, Diabetes.

[2]  C. J. Hedeskov.  Mechanism of glucose-induced insulin secretion. , 1980, Physiological reviews.

[3]  L. Regeur,et al.  Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. , 1979, British medical journal.

[4]  R. Robertson.  Prostaglandins as modulators of pancreatic islet function. , 1979, Diabetes.

[5]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[6]  J. Halter,et al.  Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. , 1979, The Journal of clinical endocrinology and metabolism.

[7]  J. Halter,et al.  Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus. , 1979, The Journal of clinical endocrinology and metabolism.

[8]  R. Holman,et al.  Maintenance of Basal Plasma Glucose and Insulin Concentrations in Maturity-Onset Diabetes , 1979, Diabetes.

[9]  G. Weir,et al.  Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. , 1979, The Journal of clinical investigation.

[10]  R. Robertson,et al.  Sounding board. Prostaglandins, the glucoreceptor, and diabetes. , 1979, The New England journal of medicine.

[11]  G. Sartor,et al.  Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. , 2009, Acta medica Scandinavica.

[12]  R. Robertson,et al.  Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog. , 1978, The Journal of clinical investigation.

[13]  J. Holst,et al.  Secretory effects of VIP on isolated perfused porcine pancreas. , 1978, The American journal of physiology.

[14]  J. Halter,et al.  Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin. , 1978, The Journal of clinical endocrinology and metabolism.

[15]  L Orci,et al.  Insulin, glucagon, and somatostatin secretion in the regulation of metabolism. , 1978, Annual review of physiology.

[16]  G. Grodsky,et al.  Pancreatic action of the sulfonylureas. , 1977, Federation proceedings.

[17]  R. Unger,et al.  Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. , 1977, The Journal of clinical investigation.

[18]  L. Orci,et al.  Possible Roles of the Pancreatic D-cell in the Normal and Diabetic States , 1977, Diabetes.

[19]  G. Grodsky,et al.  Regulation of pancreatic insulin and glucagon secretion. , 1976, Annual review of physiology.

[20]  J. Halter,et al.  A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. , 1976, The Journal of clinical investigation.

[21]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[22]  G. Reaven,et al.  Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. , 1976, The American journal of medicine.

[23]  J. Palmer,et al.  Arginine-stimulated Acute Phase of Insulin and Glucagon Secretion: I. In Normal Man , 1975, Diabetes.

[24]  W. Liston,et al.  Dangers of Oxytocin-induced Labour to Fetuses , 1974, British medical journal.

[25]  A. Barnes,et al.  Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose. , 1974, Lancet.

[26]  C. J. Goodner,et al.  Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas , 1974, Science.

[27]  J. Brown,et al.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man. , 1973, The Journal of clinical endocrinology and metabolism.

[28]  P. Felig,et al.  Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. , 1973, The Journal of clinical investigation.

[29]  D. Porte,et al.  Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. , 1973, Federation proceedings.

[30]  I. Valverde,et al.  Hyperglucagonism induced by glucocorticoid treatment in man. , 1973, The New England journal of medicine.

[31]  D. Porte,et al.  Studies of secretin-stimulated insulin responses in man. , 1972, The Journal of clinical investigation.

[32]  J. Turtle.  Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes , 1970, British medical journal.

[33]  D. Porte,et al.  Human insulin secretion: as integrated approach. , 1970, Annual review of medicine.

[34]  D. Porte,et al.  Insulin responses to glucose: evidence for a two pool system in man. , 1969, The Journal of clinical investigation.

[35]  J. Beck,et al.  Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. , 1969, The Journal of clinical investigation.

[36]  T. Kuzuya,et al.  Effects of methacholine on insulin secretion in man. , 1968, The Journal of clinical endocrinology and metabolism.

[37]  C. J. Goodner,et al.  The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. , 1968, Annals of internal medicine.

[38]  G. Reaven,et al.  Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus , 1967, Diabetes.

[39]  D. Porte,et al.  The effect of epinephrine on immunoreactive insulin levels in man. , 1966, The Journal of clinical investigation.

[40]  S. Fajans,et al.  Stimulation of insulin secretion by amino acids. , 1966, The Journal of clinical investigation.

[41]  D. Porte,et al.  Inhibition of Insulin Release by Norepinephrine in Man , 1966, Science.

[42]  V. Marks,et al.  PROMOTION OF INSULIN SECRETION BY GLUCAGON. , 1965, Lancet.

[43]  M. T. Brennan,et al.  Failure of Prolonged Sulfonylurea Administration to Enhance Insulogenic Response to Glycemic Stimulus , 1965, Diabetes.